Xenon Pharmaceuticals Inc

Common Name

Xenon Pharmaceuticals

Country

Canada

Sector

Healthcare

Industry

Biotechnology

Employees

316

Ticker

XENE

Exchange

NASDAQ/NMS

Website

www.xenon-pharma.com

Description

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. The primary functio... Show more

Income Statement Balance Sheet Group Entities

Xenon Pharmaceuticals's Financial Statements Preview

Below are the financial statements of Xenon Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

Limited Data Preview

You are viewing a limited preview of Xenon Pharmaceuticals’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).

Access Datasets, Disclosures, and Sources

pro

Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.

Download granular datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace all values back to their original sources

Start Your 30-Day Free Trial

Formats Included

Excel

CSV

Json

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Xenon Pharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Xenon Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. Xenon Pharmaceuticals's 10-K 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	142.71^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	148.64^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Marketable securities	484.19^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	489.44^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Accounts receivable	1.47^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	0.87^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Prepaid expenses and other current assets	6.89^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	6.01^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Marketable securities, long-term	127.5^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	292.79^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Operating lease right-of-use asset, net	7.94^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	9.19^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Property, plant and equipment, net	10.28^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	9.65^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Deferred tax assets	9.67^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	0.8^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Prepaid expenses, long-term	7.5^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	7.4^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Total assets	798.14^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	964.8^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Liabilities and shareholders' equity	—	—
Current liabilities	—	—
Accounts payable and accrued liabilities	34.22^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	25.97^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Operating lease liability	1.37^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	1.3^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Operating lease liability, long-term	7.65^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	9.6^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Total liabilities	43.24^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	36.88^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Shareholders' equity	—	—
Common shares	1,456.84^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	1,436.37^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Additional paid-in capital	199.15^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	156.76^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Accumulated deficit	-899.47^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-665.14^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Accumulated other comprehensive loss	-1.61^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-0.08^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Total shareholders' equity	754.9^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	927.92^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Total liabilities and shareholders' equity	798.14^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	964.8^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial

Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals's Financial Statements Preview

Xenon Pharmaceuticals's Financial Statements Preview

Verified Sources Behind Xenon Pharmaceuticals’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Ultragenyx Pharmaceutical Inc

Camurus AB

Denali Therapeutics Inc

Dyne Therapeutics Inc

Vericel Corp

Zai Lab Ltd